Base de dados : MEDLINE
Pesquisa : C10.228.140.546.399.937 [Categoria DeCS]
Referências encontradas : 156 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 16 ir para página                         

  1 / 156 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28615434
[Au] Autor:Müller KI; Alstadhaug KB; Bekkelund SI
[Ad] Endereço:From the Department of Clinical Medicine (K.I.M., K.B.A., S.I.B.), UiT-The Arctic University of Norway; Department of Neurology (K.I.M., S.I.B.), University Hospital of North Norway, Tromsø; and Department of Neurology (K.B.A.), Nordland Hospital Trust, Bodø, Norway. kai.ivar.muller@unn.no.
[Ti] Título:A randomized trial of telemedicine efficacy and safety for nonacute headaches.
[So] Source:Neurology;89(2):153-162, 2017 Jul 11.
[Is] ISSN:1526-632X
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE: To evaluate long-term treatment efficacy and safety of one-time telemedicine consultations for nonacute headaches. METHODS: We randomized, allocated, and consulted nonacute headache patients via telemedicine (n = 200) or in a traditional manner (n = 202) in a noninferiority trial. Efficacy endpoints, assessed by questionnaires at 3 and 12 months, included change from baseline in Headache Impact Test-6 (HIT-6) (primary endpoint) and pain intensity (visual analogue scale [VAS]) (secondary endpoint). The primary safety endpoint, assessed via patient records, was presence of secondary headache within 12 months after consultation. RESULTS: We found no differences between telemedicine and traditional consultations in HIT-6 ( = 0.84) or VAS ( = 0.64) over 3 periods. The absolute difference in HIT-6 from baseline was 0.3 (95% confidence interval [CI] -1.26 to 1.82, = 0.72) at 3 months and 0.2 (95% CI -1.98 to 1.58, = 0.83) at 12 months. The absolute change in VAS was 0.4 (95% CI -0.93 to 0.22, = 0.23) after 3 months and 0.3 (95% CI -0.94 to 0.29, = 0.30) at 12 months. We found one secondary headache in each group at 12 months. The estimated number of consultations needed to miss one secondary headache with the use of telemedicine was 20,200. CONCLUSION: Telemedicine consultation for nonacute headache is as efficient and safe as a traditional consultation. CLINICALTRIALSGOV IDENTIFIER: NCT02270177. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that a one-time telemedicine consultation for nonacute headache is noninferior to a one-time traditional consultation regarding long-term treatment outcome and safety.
[Mh] Termos MeSH primário: Transtornos da Cefaleia Secundários/terapia
Transtornos de Enxaqueca/terapia
Avaliação de Processos e Resultados (Cuidados de Saúde)
Manejo da Dor/métodos
Telemedicina/métodos
Cefaleia do Tipo Tensional/terapia
Cefalalgias Autonômicas do Trigêmeo/terapia
[Mh] Termos MeSH secundário: Adulto
Feminino
Seres Humanos
Masculino
Meia-Idade
Manejo da Dor/efeitos adversos
Manejo da Dor/normas
Medição da Dor
Telemedicina/normas
[Pt] Tipo de publicação:JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL
[Em] Mês de entrada:1707
[Cu] Atualização por classe:170719
[Lr] Data última revisão:
170719
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170616
[St] Status:MEDLINE
[do] DOI:10.1212/WNL.0000000000004085


  2 / 156 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27753068
[Au] Autor:Prakash S; Rathore C
[Ad] Endereço:Department of Neurology, Smt. B. K. Shah Medical Institute and Research Centre, Sumandeep Vidyapeeth University, Piparia, Baroda, Gujarat, 3901760, India.
[Ti] Título:Two Cases of Hemicrania Continua-Trigeminal Neuralgia Syndrome: Expanding the Spectrum of Trigeminal Autonomic Cephalalgia-Tic (TAC-TIC) Syndrome.
[So] Source:Headache;57(3):472-477, 2017 Mar.
[Is] ISSN:1526-4610
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Trigeminal neuralgia (TN) has been described in association with various primary headache disorders. So far, no case of TN has been reported in association with hemicrania continua (HC). CASE REPORT: Here, we report two patients of hemicrania continua associated with TN (HC-tic syndrome). These patients had both headaches concurrently. Both patients responded to a combination of carbamazepine and indomethacin. The skipping or tapering of carbamazepine led to the recurrence of the neuralgic pain of TN. In the same way, the skipping of indomethacin resulted in the relapse of the pain, typical of HC. CONCLUSION: With these two cases of HC-tic syndrome, we suggest that TN has a special predilection for all types of TACs. Various speculations suggest that such associations are more than a simple coincidence, and both diseases may be causally interrelated. The identification of this association is important as both disorders may need separate drugs.
[Mh] Termos MeSH primário: Cefalalgias Autonômicas do Trigêmeo/etiologia
Neuralgia do Trigêmeo/complicações
[Mh] Termos MeSH secundário: Adulto
Analgésicos não Entorpecentes/uso terapêutico
Anti-Inflamatórios não Esteroides/uso terapêutico
Carbamazepina/uso terapêutico
Progressão da Doença
Seres Humanos
Indometacina/uso terapêutico
Masculino
Meia-Idade
Cefalalgias Autonômicas do Trigêmeo/tratamento farmacológico
Neuralgia do Trigêmeo/tratamento farmacológico
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Analgesics, Non-Narcotic); 0 (Anti-Inflammatory Agents, Non-Steroidal); 33CM23913M (Carbamazepine); XXE1CET956 (Indomethacin)
[Em] Mês de entrada:1704
[Cu] Atualização por classe:170417
[Lr] Data última revisão:
170417
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161019
[St] Status:MEDLINE
[do] DOI:10.1111/head.12965


  3 / 156 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:27585208
[Au] Autor:Gross JR; McClelland CM; Lee MS
[Ad] Endereço:Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, Minnesota, USA.
[Ti] Título:An approach to anisocoria.
[So] Source:Curr Opin Ophthalmol;27(6):486-492, 2016 Nov.
[Is] ISSN:1531-7021
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:PURPOSE OF REVIEW: Anisocoria is a finding seen on a daily basis in nearly every eye clinic. Although often benign, it can also represent the sole sign of a life-threatening disease making an up-to-date understanding of pathophysiology and diagnosis essential for anyone practicing medicine. RECENT FINDINGS: Many aspects of the traditional approach to anisocoria still hold true today, but advancements in imaging technology and changing trends in pharmacologic diagnosis and localization have led many to rethink that approach. In addition, the differential diagnosis for anisocoria continuously expands with identification and improved understanding of causal disease processes. SUMMARY: The present article discusses an approach to the classic anisocoria diagnostic algorithm modified by current knowledge from the most recent literature.
[Mh] Termos MeSH primário: Anisocoria/diagnóstico
Anisocoria/etiologia
[Mh] Termos MeSH secundário: Algoritmos
Anisocoria/diagnóstico por imagem
Doenças Autoimunes/complicações
Doenças Autoimunes/diagnóstico
Doenças do Sistema Nervoso Autônomo/complicações
Doenças do Sistema Nervoso Autônomo/diagnóstico
Diagnóstico Diferencial
Gânglios Autônomos
Síndrome de Horner/complicações
Síndrome de Horner/diagnóstico por imagem
Seres Humanos
Neuroanatomia
Doenças do Nervo Oculomotor/complicações
Doenças do Nervo Oculomotor/diagnóstico
Pupila Tônica/complicações
Pupila Tônica/diagnóstico
Cefalalgias Autonômicas do Trigêmeo/complicações
Cefalalgias Autonômicas do Trigêmeo/diagnóstico
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1612
[Cu] Atualização por classe:161230
[Lr] Data última revisão:
161230
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160902
[St] Status:MEDLINE


  4 / 156 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27063627
[Au] Autor:Mathew T; Nadimpally US; Sarma GR; Nadig R
[Ad] Endereço:St.John's Medical College and Hospital, India. Electronic address: chakkuthom@hotmail.com.
[Ti] Título:Trigeminal autonomic cephalalgia as a presenting feature of Neuromyelitis Optica: "A rare combination of two uncommon disorders".
[So] Source:Mult Scler Relat Disord;6:73-4, 2016 Mar.
[Is] ISSN:2211-0356
[Cp] País de publicação:Netherlands
[La] Idioma:eng
[Ab] Resumo:Neuromyelitis Optica (NMO) can have atypical presentations like hiccups, vomiting, etc. which is classically described as the area postrema syndrome. Here we report a case of a 39 year old male patient who presented with features of Trigeminal Autonomic Cephalalgia (TAC). MRI spine showed long segment myelitis. Diagnosis of NMO was confirmed by a positive Anti aquaporin 4 antibody assay. TACs are a rare group of headache disorders characterized by severe unilateral headache in the V1 distribution of the trigeminal nerve and autonomic symptoms. This presentation in NMO is hitherto unreported in literature.
[Mh] Termos MeSH primário: Neuromielite Óptica/diagnóstico
Cefalalgias Autonômicas do Trigêmeo/diagnóstico
[Mh] Termos MeSH secundário: Adulto
Medula Cervical/diagnóstico por imagem
Diagnóstico Diferencial
Seres Humanos
Imagem por Ressonância Magnética
Masculino
Bulbo/diagnóstico por imagem
Neuromielite Óptica/tratamento farmacológico
Neuromielite Óptica/fisiopatologia
Cefalalgias Autonômicas do Trigêmeo/tratamento farmacológico
Cefalalgias Autonômicas do Trigêmeo/fisiopatologia
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1612
[Cu] Atualização por classe:161230
[Lr] Data última revisão:
161230
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160412
[St] Status:MEDLINE


  5 / 156 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26817035
[Au] Autor:Rojas-Ramirez MV; Bertoli E; Smith JH
[Ti] Título:Short-Lasting Unilateral Neuralgiform Headache with Conjunctival Injection and Tearing Secondary to Head and Neck Trauma: Literature Review and Case Report.
[So] Source:J Oral Facial Pain Headache;30(1):68-72, 2016.
[Is] ISSN:2333-0384
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:This article reports a case of secondary short-lasting unilateral neuralgiform headache with conjunctival injection and tearing following head and neck trauma due to a violent assault. Following the incident, the patient began experiencing 4 to 30 shooting/sharp pain attacks per day in the left anterior temporal and supraorbital areas, with an intensity of 10/10 on a numeric rating scale. Each attack lasted between 10 and 60 seconds. These attacks were accompanied by ipsilateral conjunctival injection, tearing, ptosis of the left eye, blurry vision, and occasional rhinorrhea. Significant improvements in sleep, autonomic symptoms, and pain were observed with a combination of melatonin 10 mg per day, gabapentin 300 mg twice daily, physical therapy, and psychotherapy. This case highlights the relevance of a multidisciplinary approach in the treatment of challenging cases when there is evidence of more than one contributing factor, with the aim of reducing pain and improving the patient's quality of life.
[Mh] Termos MeSH primário: Traumatismos Craniocerebrais/complicações
Lesões do Pescoço/complicações
Cefalalgias Autonômicas do Trigêmeo/diagnóstico
[Mh] Termos MeSH secundário: Aminas/uso terapêutico
Depressores do Sistema Nervoso Central/uso terapêutico
Ácidos Cicloexanocarboxílicos/uso terapêutico
Diagnóstico Diferencial
Antagonistas de Aminoácidos Excitatórios/uso terapêutico
Técnicas de Exercício e de Movimento
Feminino
Seguimentos
Seres Humanos
Melatonina/uso terapêutico
Meia-Idade
Psicoterapia
Transtornos da Articulação Temporomandibular/diagnóstico
Cefalalgias Autonômicas do Trigêmeo/etiologia
Violência
Ácido gama-Aminobutírico/uso terapêutico
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Amines); 0 (Central Nervous System Depressants); 0 (Cyclohexanecarboxylic Acids); 0 (Excitatory Amino Acid Antagonists); 56-12-2 (gamma-Aminobutyric Acid); 6CW7F3G59X (gabapentin); JL5DK93RCL (Melatonin)
[Em] Mês de entrada:1603
[Cu] Atualização por classe:160128
[Lr] Data última revisão:
160128
[Sb] Subgrupo de revista:D
[Da] Data de entrada para processamento:160128
[St] Status:MEDLINE
[do] DOI:10.11607/ofph.1549


  6 / 156 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26453658
[Au] Autor:May A; Goadsby P
[Ad] Endereço:Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Germany a.may@uke.de.
[Ti] Título:The enigma of the interconnection of trigeminal pain and cranial autonomic symptoms.
[So] Source:Cephalalgia;36(8):727-9, 2016 Jul.
[Is] ISSN:1468-2982
[Cp] País de publicação:England
[La] Idioma:eng
[Mh] Termos MeSH primário: Cefalalgias Autonômicas do Trigêmeo/diagnóstico
Cefalalgias Autonômicas do Trigêmeo/fisiopatologia
[Mh] Termos MeSH secundário: Seres Humanos
[Pt] Tipo de publicação:EDITORIAL
[Em] Mês de entrada:1703
[Cu] Atualização por classe:170817
[Lr] Data última revisão:
170817
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:151011
[St] Status:MEDLINE
[do] DOI:10.1177/0333102415611410


  7 / 156 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:24888770
[Au] Autor:Eller M; Goadsby PJ
[Ad] Endereço:Headache Center-Department of Neurology, University of California, San Francisco, CA, USA.
[Ti] Título:Trigeminal autonomic cephalalgias.
[So] Source:Oral Dis;22(1):1-8, 2016 Jan.
[Is] ISSN:1601-0825
[Cp] País de publicação:Denmark
[La] Idioma:eng
[Ab] Resumo:The trigeminal autonomic cephalalgias (TACs) are a group of primary headache disorders characterised by lateralized symptoms: prominent headache and ipsilateral cranial autonomic features, such as conjunctival injection, lacrimation and rhinorrhea. The TACs are: cluster headache (CH), paroxysmal hemicrania (PH), short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT)/short-lasting neuralgiform headache attacks with cranial autonomic features (SUNA) and hemicrania continua (HC). Their diagnostic criteria are outlined in the International Classification of Headache Disorders, third edition-beta (ICHD-IIIb). These conditions are distinguished by their attack duration and frequency, as well as response to treatment. HC is continuous and by definition responsive to indomethacin. The main differential when considering this headache is chronic migraine. Other TACs are remarkable for their short duration and must be distinguished from other short-lasting painful conditions, such as trigeminal neuralgia and primary stabbing headache. Cluster headache is characterised by exquisitely painful attacks that occur in discrete episodes lasting 15-180 min a few times a day. In comparison, PH occurs more frequently and is of shorter duration, and like HC is responsive to indomethacin. SUNCT/SUNA is the shortest duration and highest frequency TAC; attacks can occur over a hundred times every day.
[Mh] Termos MeSH primário: Cefalalgias Autonômicas do Trigêmeo/fisiopatologia
[Mh] Termos MeSH secundário: Sistema Nervoso Autônomo/fisiopatologia
Diagnóstico Diferencial
Seres Humanos
Cefalalgias Autonômicas do Trigêmeo/diagnóstico
Cefalalgias Autonômicas do Trigêmeo/tratamento farmacológico
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1702
[Cu] Atualização por classe:170214
[Lr] Data última revisão:
170214
[Sb] Subgrupo de revista:D
[Da] Data de entrada para processamento:140604
[St] Status:MEDLINE
[do] DOI:10.1111/odi.12263


  8 / 156 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:26775310
[Au] Autor:Böger A
[Ti] Título:[Trigemino-autonomous headaches (TAH)--conservative and interventional options].
[Ti] Título:Trigeminoautonome Kopfschmerzen (TAK)-- konservative und operative Therapieverfahren..
[So] Source:Versicherungsmedizin;67(4):197-200, 2015 Dec 01.
[Is] ISSN:0933-4548
[Cp] País de publicação:Germany
[La] Idioma:ger
[Ab] Resumo:Trigemino-autonomous headaches (TAH) are relatively rare, thus physicians are not familiar with the diagnostic and therapeutic procedures. In terms of their intensity and duration, they differ distinctly from other primary headaches such as migraine or tension-type headache. Nevertheless, patients experience a significant psychosocial burden and therefore economic consequences, i.e. direct and indirect costs. Fast diagnosis and optimised treatment should lead to significant improvements. This article aims to offer advice by detailing appropriate classification systems and guideline-based treatment strategies.
[Mh] Termos MeSH primário: Analgésicos/uso terapêutico
Procedimentos Neurocirúrgicos/métodos
Guias de Prática Clínica como Assunto
Cefalalgias Autonômicas do Trigêmeo/diagnóstico
Cefalalgias Autonômicas do Trigêmeo/terapia
[Mh] Termos MeSH secundário: Diagnóstico Diferencial
Alemanha
Seres Humanos
Resultado do Tratamento
Cefalalgias Autonômicas do Trigêmeo/classificação
[Pt] Tipo de publicação:ENGLISH ABSTRACT; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Analgesics)
[Em] Mês de entrada:1602
[Cu] Atualização por classe:161021
[Lr] Data última revisão:
161021
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160119
[St] Status:MEDLINE


  9 / 156 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
PubMed Central Texto completo
[PMID]:26411963
[Au] Autor:Costa A; Antonaci F; Ramusino MC; Nappi G
[Ad] Endereço:National Institute of Neurology IRCCS C. Mondino Foundation, University of Pavia, via Mondino 2, 27100 Pavia, Italy. alfredo.costa@mondino.it.
[Ti] Título:The Neuropharmacology of Cluster Headache and other Trigeminal Autonomic Cephalalgias.
[So] Source:Curr Neuropharmacol;13(3):304-23, 2015.
[Is] ISSN:1875-6190
[Cp] País de publicação:United Arab Emirates
[La] Idioma:eng
[Ab] Resumo:Trigeminal autonomic cephalalgias (TACs) are a group of primary headaches including cluster headache (CH), paroxysmal hemicrania (PH) and short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT). Another form, hemicrania continua (HC), is also included this group due to its clinical and pathophysiological similarities. CH is the most common of these syndromes, the others being infrequent in the general population. The pathophysiology of the TACs has been partly elucidated by a number of recent neuroimaging studies, which implicate brain regions associated with nociception (pain matrix). In addition, the hypothalamic activation observed in the course of TAC attacks and the observed efficacy of hypothalamic neurostimulation in CH patients suggest that the hypothalamus is another key structure. Hypothalamic activation may indeed be involved in attack initiation, but it may also lead to a condition of central facilitation underlying the recurrence of pain episodes. The TACs share many pathophysiological features, but are characterised by differences in attack duration and frequency, and to some extent treatment response. Although alternative strategies for the TACs, especially CH, are now emerging (such as neurostimulation techniques), this review focuses on the available pharmacological treatments complying with the most recent guidelines. We discuss the clinical efficacy and tolerability of the currently used drugs. Due to the low frequency of most TACs, few randomised controlled trials have been conducted. The therapies of choice in CH continue to be the triptans and oxygen for acute treatment, and verapamil and lithium for prevention, but promising results have recently been obtained with novel modes of administration of the triptans and other agents, and several other treatments are currently under study. Indomethacin is extremely effective in PH and HC, while antiepileptic drugs (especially lamotrigine) appear to be increasingly useful in SUNCT. We highlight the need for appropriate studies investigating treatments for these rare, but lifelong and disabling conditions.
[Mh] Termos MeSH primário: Cefaleia Histamínica/tratamento farmacológico
Cefaleia/tratamento farmacológico
Neurofarmacologia
Hemicrania Paroxística/tratamento farmacológico
Síndrome SUNCT/tratamento farmacológico
Cefalalgias Autonômicas do Trigêmeo/tratamento farmacológico
[Mh] Termos MeSH secundário: Animais
Seres Humanos
Neurofarmacologia/métodos
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1608
[Cu] Atualização por classe:170220
[Lr] Data última revisão:
170220
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:150929
[St] Status:MEDLINE


  10 / 156 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26252590
[Au] Autor:Newman LC
[Ti] Título:Trigeminal Autonomic Cephalalgias.
[So] Source:Continuum (Minneap Minn);21(4 Headache):1041-57, 2015 Aug.
[Is] ISSN:1538-6899
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:PURPOSE OF REVIEW: This article reviews the clinical features of and treatment options for the trigeminal autonomic cephalalgias (TACs). RECENT FINDINGS: The TACs are a group of primary headache disorders characterized by short-lasting episodes of severe unilateral headaches that are associated with ipsilateral cranial autonomic symptoms. The best known and most commonly seen TAC in clinical practice is cluster headache. The other syndromes within this group include paroxysmal hemicrania, hemicrania continua, and short-lasting unilateral neuralgiform headache attacks. Although these disorders share a similar phenotype, they are distinguished by differences in attack frequency and duration. Recognition of these clinical differences is paramount because treatment options vary; paroxysmal hemicrania and hemicrania continua demonstrate an absolute response to treatment with indomethacin, while the other syndromes respond to other agents. SUMMARY: Although much less common than other headache disorders seen in clinical practice, recognition of the TACs is especially important as they are among the most severe and disabling syndromes in headache medicine.
[Mh] Termos MeSH primário: Gerenciamento Clínico
Cefalalgias Autonômicas do Trigêmeo/diagnóstico
Cefalalgias Autonômicas do Trigêmeo/terapia
[Mh] Termos MeSH secundário: Seres Humanos
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1610
[Cu] Atualização por classe:161230
[Lr] Data última revisão:
161230
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:150808
[St] Status:MEDLINE
[do] DOI:10.1212/CON.0000000000000190



página 1 de 16 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde